Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Authors' Reply to the Letter to the Editor by Stimac and Bayley: Utilization of Cancer Screening, Prevention, and Treatment in Women With Variants of Uncertain Significance in Breast Cancer Susceptibility Genes.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 11, 2026
Neoadjuvant Chemotherapy for T3 Tumors in the Era of Precision Medicine-Biology Is Still King.
Journal: International journal of molecular sciences
Published: December 07, 2024
Utilization of Cancer Screening, Prevention, and Treatment in Women With Variants of Uncertain Significance in Breast Cancer Susceptibility Genes.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: October 09, 2024
Tyrer-Cuzick Lifetime Risk Is Not Associated With Non-BRCA1/2 Pathogenic Variants for Breast Carcinoma.
Journal: The breast journal
Published: September 10, 2024
Neoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 09, 2024
Cascade testing for hereditary cancer: comprehensive multigene panels identify unexpected actionable findings in relatives.
Journal: Journal of the National Cancer Institute
Published: July 24, 2023
Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.
Journal: JAMA network open
Published: September 22, 2022
Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy.
Journal: JCO precision oncology
Published: September 15, 2022
Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome in early-stage breast cancer.
Journal: Surgical oncology
Published: July 18, 2022
Clinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence-Guided System: A Nonrandomized Controlled Trial.
Journal: JAMA surgery
Published: May 11, 2022
Last Updated: 09/26/2026